Register
Login:
Share:
Email Facebook Twitter

Is the Bull Market over? Andre Minassian says no! Watch here

Is the Bull Market over? Andre Minassian says no!


Reneuron Share Price (RENE)



Share Price Information for Reneuron (RENE)


Share Price: 2.65Bid: 2.40Ask: 2.75Change: 0.00 (0.00%)No Movement on Reneuron
Spread: 0.35Spread as %: 14.58%Open: 2.575High: 2.65Low: 2.575Yesterday’s Close: 2.65

Reneuron Group Plc Ord 1P

Reneuron is listed in the FTSE AIM All-Share
Reneuron is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
2.65

Share Price SpacerBid
2.40

Share Price SpacerAsk
2.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
814,089

Share Price SpacerOpen
2.575

Share Price SpacerHigh
2.65

Share Price SpacerLow
2.575

Share Price SpacerClose
2.65

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 3,164.62m £83.86m 100,000

52 Week High 3.75 52 Week High Date 15-MAR-2016
52 Week Low 2.31 52 Week Low Date 18-OCT-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
9 12,930 801,159 -6.625 -0.40 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Jan-17
16:35:13
2.65
408,957
Buy* 
2.40
2.75
10.84k
UT 
Trade Type:
Uncrossing Trade

20-Jan-17
16:28:29
2.645
3,709
Buy* 
2.40
2.75
98.10
Trade Type:
Ordinary

20-Jan-17
15:09:32
2.645
8,752
Buy* 
2.40
2.75
231.49
Trade Type:
Ordinary




View more Reneuron trades >>

Directors Deals for Reneuron (RENE)
Trade DateActionNotifierPriceCurrencyAmountHolding
31-Mar-16Notification of Holding
Trade Notifier Information for ReNeuron Group
Simon Christopher Cartmell held the position of Non-Executive Director at ReNeuron Group at the time of this trade.
 Simon Christopher Cartmell
00787500
31-Mar-16Notification of Holding
Trade Notifier Information for ReNeuron Group
Timothy (Tim) Corn held the position of Non-Executive Director at ReNeuron Group at the time of this trade.
 Timothy (Tim) Corn
00200000
31-Mar-16Notification of Holding
Trade Notifier Information for ReNeuron Group
Christopher Evans held the position of Non-Executive Director at ReNeuron Group at the time of this trade.
 Christopher Evans
0024010525
View more Reneuron directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Sun 21:07hymsArticle2.65No Opinion
Sun 09:47Fredd1eboyAndrew Marrs stroke treatment2.65No Opinion
''Andrew Marr's stroke treatment in America results in subtle changes but not 'dramatic improvements''

Even so, the BBC plan to run a documentary in January....so soon..

Mindful its a US treatment, I sincerely hope Reneuron get a plug on the program and they don't favor a US treatment without giving UK trials a fair airing.

If I was Reneuron I'd be on the hot line to Buchanan / UK Welsh Government Office to ensure its not a classic ignore of Reneuron.

Freddie
Sat 19:16micksnags1RE: Has anyone any idea of the timing .2.65No Opinion
i`ve been looking for news myself fred. the website offers little in updates and the bod here are happy to stay schtum . atb
Sat 08:22Fredd1eboyHas anyone any idea of the timing .2.65No Opinion
---of the opening of Reneurons manufacturing plant. Obviously the licensing process will have probably been tortuous but I hoping we must surely be on the home straight?
Anyone closer to the action or better informed have any idea?
I guess it will be a very formal affair so lead time for invitations will have to be factored in but is anyone closer to the action able to comment?
Best wishes.
Freddie
Thu 17:50Fredd1eboyc/o mol iii site2.65No Opinion
bit here from 18th Jan

http://www.aop.org.uk/ot/science-and-vision/research/2017/01/18/the-view-ahead-for-stem-cell-therapy

full extract below

With the pleasing progress of its retinal stem cell therapy, UK research company ReNeuron has started planning a larger clinical trial of the potential new treatment for next year.

The therapy uses human stem cells – transformed into young retinal cells – that are injected into the eyes of patients with retinitis pigmentosa… Read More
Thu 17:47Fredd1eboyDecent final trade2.65No Opinion
Time 16:35:22
Price 2.65p
Vol 2,221,958
Value £58,882

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Reneuron (RENE) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.